Couche-Tard restarts share buybacks after ending Seven & i takeover bid
Laval, Que.-based Couche-Tard says the Toronto Stock Exchange had approved its program to buy back up to 10 per cent of outstanding shares that, based on its current price, represents about $5.8 billion in shares.
The company says the potential repurchasing of about 77.1 million shares is an appropriate use of its cash and an efficient way to create long-term shareholder value.
Couche-Tard had been keeping funds on-hand as it tried for more than a year to land a friendly takeover of Japan-based Seven & i Holdings Co. Ltd. in a deal that could have been worth more than $60 billion.
The company said last Wednesday it had withdrawn its proposal, citing a lack of constructive engagement from Seven & i.
Seven & i said it had engaged in good-faith discussions, but had also expressed concerns about antitrust hurdles and the broad shifts in the global economy that would challenge the prospects of any deal.
Monday Mornings
The latest local business news and a lookahead to the coming week.
This report by The Canadian Press was first published July 21, 2025.
Companies in this story: (TSX:ATD)
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Cision Canada
a few seconds ago
- Cision Canada
Canadian Investment Regulatory Organization Trading Halt - ARIS.WT.A Français
TORONTO, /CNW/ - The following issues have been halted by CIRO: Company: Aris Mining Corporation TSX Symbol: All Issues: No Reason: Pending Delisting Halt Time (ET): 12:00 PM CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. CIRO is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada. SOURCE Canadian Investment Regulatory Organization (CIRO) – Halts/Resumptions For further information about CIRO's trading halt policy, please see Trading Halts & Timely Disclosure at under the Markets tab. Please note that CIRO staff cannot provide any information about a specific halt beyond what is contained in this halt notice. For general information about CIRO, contact CIRO's Complaints & Inquiries team by submitting a Secure Form located on our contact page at or dialing 1-877-442-4322 (Option 1). For company-related enquiries, please contact the company directly.
Cision Canada
a few seconds ago
- Cision Canada
DOLLARAMA TO REPORT SECOND QUARTER FISCAL 2026 RESULTS Français
MONTREAL, July 29, 2025 /CNW/ - Dollarama Inc. (TSX: DOL) ("Dollarama") will issue its financial results for the second quarter of Fiscal 2026, covering the period from May 5, 2025 to August 3, 2025, on Wednesday, August 27, 2025 at 7:00 a.m. (ET). Management will hold a conference call on the same day to discuss the results. Financial analysts are invited to ask questions by using the call link provided below. Other interested parties may participate in the call on a listen‑only basis via live audio webcast which will be available on Dollarama's website. About Dollarama Founded in 1992 and headquartered in Montréal, Quebec, Canada, Dollarama is a recognized Canadian value retailer offering a broad assortment of consumable products, general merchandise and seasonal items both in-store and online. With stores in all Canadian provinces and two territories, our 1,638 locations across Canada provide customers with compelling value in convenient locations, including metropolitan areas, mid-sized cities and small towns. Our quality merchandise is sold at select fixed price points up to $5.00. Dollarama also owns a 60.1% interest in Dollarcity, a growing Latin American value retailer. Dollarcity offers a broad assortment of consumable products, general merchandise and seasonal items at select, fixed price points up to US$4.00 (or the equivalent in local currency) in 644 conveniently located stores in Colombia, Guatemala, El Salvador and Peru.
Cision Canada
12 minutes ago
- Cision Canada
Cipher Pharmaceuticals Schedules Q2 2025 Earnings Release and Conference Call
MISSISSAUGA, ON, July 29, 2025 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) (" Cipher" or the " Company") today announced that it will release its financial results for the second quarter of 2025 after the market close on Thursday, August 7, 2025. The Company will also hold a conference call on Friday, August 8, 2025 at 8:30am ET to discuss the results and corporate developments. CONFERENCE CALL DETAILS About Cipher Pharmaceuticals Inc. Cipher Pharmaceuticals (TSX: CPH) (OTCQX: CPHRF) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products, mainly in dermatology. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products in Canada, the U.S., and South America. For more information, visit SOURCE Cipher Pharmaceuticals Inc.
